ARTICLE | Clinical News
Searle starts Phase III study
January 26, 2000 8:00 AM UTC
Searle began a multinational Phase III trial of its eplerenone selective aldosterone receptor antagonists in 6,200 patients to treat heart failure due to myocardial infarction. ...